As of 2025-11-13, the Relative Valuation of Isofol Medical AB (publ) (ISOFOL.ST) is (5.43) SEK. This relative valuation is based on P/E multiples. With the latest stock price at 0.70 SEK, the upside of Isofol Medical AB (publ) based on Relative Valuation is -880.9%.
The range of the Relative Valuation is (5.29) - (5.79) SEK.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.4x - 37.2x | 32.4x |
| Forward P/E multiples | 25.1x - 31.1x | 26.0x |
| Fair Price | (5.29) - (5.79) | (5.43) |
| Upside | -860.6% - -932.8% | -880.9% |
| Date | P/E |
| 2025-11-11 | -3.68 |
| 2025-11-10 | -3.74 |
| 2025-11-07 | -3.76 |
| 2025-11-06 | -3.73 |
| 2025-11-05 | -3.76 |
| 2025-11-04 | -3.69 |
| 2025-11-03 | -3.68 |
| 2025-10-31 | -3.71 |
| 2025-10-30 | -3.69 |
| 2025-10-29 | -3.70 |
| 2025-10-28 | -3.74 |
| 2025-10-27 | -3.72 |
| 2025-10-24 | -3.75 |
| 2025-10-23 | -3.73 |
| 2025-10-22 | -3.80 |
| 2025-10-21 | -3.87 |
| 2025-10-20 | -3.87 |
| 2025-10-17 | -3.93 |
| 2025-10-16 | -3.98 |
| 2025-10-15 | -4.03 |
| 2025-10-14 | -4.06 |
| 2025-10-13 | -4.03 |
| 2025-10-10 | -3.95 |
| 2025-10-09 | -4.01 |
| 2025-10-08 | -4.03 |
| 2025-10-07 | -4.03 |
| 2025-10-06 | -4.06 |
| 2025-10-03 | -4.22 |
| 2025-10-02 | -4.17 |
| 2025-10-01 | -4.24 |
| 2025-09-30 | -4.30 |
| 2025-09-29 | -4.25 |
| 2025-09-26 | -4.35 |
| 2025-09-25 | -4.27 |
| 2025-09-24 | -4.35 |
| 2025-09-23 | -4.41 |
| 2025-09-22 | -4.35 |
| 2025-09-19 | -4.33 |
| 2025-09-18 | -4.30 |
| 2025-09-17 | -4.33 |
| 2025-09-16 | -4.40 |
| 2025-09-15 | -4.43 |
| 2025-09-12 | -4.25 |
| 2025-09-11 | -4.28 |
| 2025-09-10 | -4.38 |
| 2025-09-09 | -4.35 |
| 2025-09-08 | -4.57 |
| 2025-09-05 | -4.38 |
| 2025-09-04 | -4.42 |
| 2025-09-03 | -4.39 |